Search Results for "conflict of interest"
A ‘microbiome’ skin lotion tested on 5 people gets little scrutiny by AP
The trial was designed to test safety, yet the thrust of the story is about the skin cream’s potential to boost “the body’s overall immune defenses.”
Scientists mix friendly bacteria into lotions to ward off bad germs
HealthDay’s story on stem cells for aggressive MS is upfront about death risk
But the story would have been stronger if it had made it clearer that this was not an experimental trial.
Stem Cell Transplants May Help Some With Multiple Sclerosis
TIME is upfront about new psoriasis drug’s black box warning for suicidal behavior risk
Given the suicide risk, news stories ideally emphasize that it remains unclear how this new treatment will compare in terms of effectiveness and safety to existing medicines.
How a New Psoriasis Drug Is Different From Others
PR release touts big numbers in HRT protection against dementia studies, but ignores important numbers
The seemingly massive study size of the studies summarized here overshadow the minimal effects from hormone therapy.
Postmenopausal hormone therapy exceeding ten years may protect from dementia
‘Elegant’ delivery of estrogen therapy for painful intercourse? Useful measurement missing in PR release
What are the costs, harms, benefits, evidence, and novelty surrounding this estrogen treatment for vaginal dryness? The release doesn’t say.
High rates of satisfaction for applicator free local estrogen softgel ovule
In story on vision-improving headset, WSJ left most important detail in the dark
This is a story that’s long on anecdote (from a company spokesperson) and short on medical evidence.
For the Blind, an Actual-Reality Headset
FDA announces approval of new psoriasis drug with strong caveats on harms, but no data to support benefit claim
News release on a new injectable biologic drug for psoriasis comes with strong cautions about side effects, but incomplete description of the evidence.
FDA approves new psoriasis drug
Invasive weed kills superbugs? All we know is it might work in mice
Preliminary rodent research rarely (if ever) rises to the occasion of big health news. We generally recommend putting these studies away and waiting until more conclusive human research comes along.
Common weed could help fight deadly superbug, study finds
Benefits of testosterone therapy in reducing risk of heart disease remain murky, despite claims from Bayer-funded researchers
This release on an observational study of men taking testosterone therapy compared with those who did not fails to bring clarity to the testosterone replacement therapy research landscape.
Testosterone therapy provides protection against cardiovascular disease in men with low testosterone
A randomized trial of rectal cancer treatment strategies is newsworthy, so why leave out numbers backing the claims?
Data on the benefits of the various rectal cancer treatments studied would have helped readers assess the significance of the research announcement.
New method reduces adverse effects of rectal cancer treatment
‘The most effective intervention we have:’ NY Times glosses over risks of bariatric surgery
Benefits are discussed at length, but only in vague terms.
Why Weight Loss Surgery Works When Diets Don’t
In story on experimental blood test, CNN goes where few dare–the test’s sensitivity and specificity
Readers of this story will be given a mostly thorough, non-hyped account of what a new study found.
Blood test might make Parkinson's diagnosis easier, study says
On Amgen’s heels, Bayer follows with data-free release touting ‘overwhelming’ benefit
Another drug study preview leaves readers wanting data.
Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early
An app a day keeps pregnancy away? BuzzFeed’s informative look at Natural Cycles app gets a gold star
The story is balanced, provides an excellent summary of the research on the app’s effectiveness for preventing pregnancy, and makes clear the limits of the evidence.
This App Says It’s As Good As The Pill At Preventing Pregnancy, But Experts Want More Evidence
Laryngeal cancer treatment: PR release is strong on context but skips limitations
The release doesn’t mention that this was a retrospective, observational study, not a clinical trial, which is an important limitation. Correlation doesn’t equal causation.